LivaNova PLC (NASDAQ:LIVN) shares traded 1.36% higher at $44.05 on Wall Street last session.
In accordance with the data, 10 analysts cover LivaNova PLC (NASDAQ:LIVN). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $82.00 and a low of $54.00, we find $58.00. Given the previous closing price of $43.46, this indicates a potential upside of 33.46 percent. LIVN stock price is now -12.76% away from the 50-day moving average and -11.48% away from the 200-day moving average. The market capitalization of the company currently stands at $2.37B.
It has been rated a hold by 5 analysts and a buy by 5. Brokers who have rated the stock have averaged $61.89 as their price target over the next twelve months.
With the price target of $52, HSBC Securities recently initiated with Hold rating for LivaNova PLC (NASDAQ: LIVN).
In other news, McDonald Damien, CEO sold 2,220 shares of the company’s stock on Mar 30. The stock was sold for $94,461 at an average price of $42.55. Upon completion of the transaction, the CEO now directly owns 111,847 shares in the company, valued at $4.93 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 15, CEO McDonald Damien sold 2,220 shares of the business’s stock. A total of $121,123 was realized by selling the stock at an average price of $54.56. This leaves the insider owning 83,749 shares of the company worth $3.69 million. Insiders disposed of 46,145 shares of company stock worth roughly $2.03 million over the past 1 year. A total of 0.48% of the company’s stock is owned by insiders.
LivaNova PLC (NASDAQ: LIVN) opened at $44.14 on Wednesday. During the past 12 months, LivaNova PLC has had a low of $40.26 and a high of $59.86. As of last week, the company has a debt-to-equity ratio of 0.51, a current ratio of 3.23, and a quick ratio of 2.68. The fifty day moving average price for LIVN is $50.49 and a two-hundred day moving average price translates $49.76 for the stock.
The latest earnings results from LivaNova PLC (NASDAQ: LIVN) was released for Sep, 2023. According to the Medical Devices Company, earnings per share came in at $0.73, beating analysts’ expectations of $0.64 by 0.09. This compares to -$2.01 EPS in the same period last year. The net profit margin was 0.26% and return on equity was 0.24% for LIVN. The company reported revenue of $286.11 million for the quarter, compared to $252.6 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.26 percent. For the current quarter, analysts expect LIVN to generate $288.01M in revenue.
